Related content

Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies

By Robinson J.B.   Singh D.   Bodurka-Bevers D.C.   Wharton J.T.   Gershenson D.M.   Wolf J.K.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 550-558

Elsevier

Access to resources Recommend Favorite

Oral etoposide in patients with hematological malignancies: A clinical and pharmacokinetic study

By Ösby E.   Liliemark E.   Björkholm M.   Liliemark J.  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 269-275

Humana Press, Inc

Access to resources Recommend Favorite

The Antiemetic Efficacy of Oral Ondansetron plus Intravenous Dexamethasone in Patients with Gynecologic Malignancies Receiving Carboplatin-Based Chemotherapy

By Markman M.   Kennedy A.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 43-46

Elsevier

Access to resources Recommend Favorite

Prolonged Intermittent Oral Topotecan in Patients with Refractory and/or Advanced Malignancies: A Phase I Study

By Suzanne F. Jones  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 317-324

Adis International

Access to resources Recommend Favorite

A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies

By Gallerani Elisa   Bauer Jean   Hess Dagmar   Boehm Steffen   Droege Cornelia   Jeckelmann Sandrine   Miani Monica   Herrmann Richard   Marsoni Silvia   Sperka Sabine   Sessa Cristiana  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1105-1110

Informa Healthcare

Access to resources Recommend Favorite